14 studies found for:    CONE-ROD DYSTROPHY 1
Show Display Options
Rank Status Study
1 Recruiting NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
Condition: Foot Ulcer, Diabetic
Interventions: Other: NEOX® CORD 1K;   Procedure: Standard of Care (Pressure Bandage)
2 Recruiting Peroneal and Achilles Tendon Repair Indications With CLARIX® CORD 1K
Condition: Peroneal and Achilles Tendon Tears
Intervention: Biological: CLARIX® CORD 1K graft
3 Active, not recruiting Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy
Conditions: Retinitis Pigmentosa,;   Cone Rod Dystrophy,;   Choroideremia
Intervention: Device: Intelligent Retinal Implant System
4 Recruiting Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention: Genetic: UshStat
5 Recruiting Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
Conditions: Inherited Ophthalmic Diseases;   Inherited Retinal Degeneration
Intervention: Drug: Interferon gamma-1b
6 Recruiting AUgmented REality for the Visually Impaired - Part 1
Conditions: Retinitis Pigmentosa;   Glaucoma
Interventions: Procedure: Find visual comfort threshold related to light intensity;   Procedure: Find the size of the visual field;   Procedure: Effectiveness of brightness control;   Procedure: Performance of color correction;   Device: Vuzix Wrap 1200DX virtural reality glasses
7 Completed Study of Usher Syndromes, Type 1 and Type 2
Condition: Retinitis Pigmentosa
Intervention:
8 Completed Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: intravitreal injection of autologous bone marrow stem cells
9 Completed Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Conditions: LCA (Leber Congenital Amaurosis);   RP (Retinitis Pigmentosa)
Intervention: Drug: QLT091001
10 Completed Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
Condition: Retinitis Pigmentosa (RP)
Intervention: Drug: QLT091001
11 Suspended Repository for Inherited Eye Diseases
Conditions: Retinitis Pigmentosa;   Inherited Ophthalmic Diseases
Intervention:
12 Completed Microcurrent Stimulation to Treat Macular Degeneration
Conditions: Retinal Diseases;   Stargardt's Disease;   Retinitis Pigmentosa
Intervention:
13 Enrolling by invitation A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B
Condition: Usher Syndrome
Intervention: Drug: UshStat
14 Active, not recruiting Gene Therapy for Blindness Caused by Choroideremia
Condition: Choroideremia
Intervention: Drug: rAAV2.REP1

Indicates status has not been verified in more than two years